https://www.marketscreener.com/quote/stock/HANSA-BIOPHARMA-AB-59968331/news/Hansa-Biopharma-Announces-First-Patient-Treated-in-the-Post-Authorization-Efficacy-Study-of-Idefirix-40952770/?utm_source=telegram&utm_medium=social&utm_campaign=share